Telesis Bio
在场
Telesis Bio 是一家在股票代码 DNAY (US) 下上市的公司。
高管
查看带有其 14 名主要高管的组织结构图
Telesis Bio 搜索最多的简介
- Eric Esser, President, Chief Executive Officer and Chairman of the...
- Jim Weissman, Director
- Steven Golub, Director
高管在Telesis Bio变化
- Eric Esser 曾任 Chief Operating Officer, 现升职为 Chief Executive Officer and Director (新闻发布的2024四月19号).
创建提醒
跟踪 Telesis Bio 的高管变动
生物技术
Telesis Bio 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Telesis Bio 的最新新闻稿
- Codex DNA to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 - CODEX DNA
- Codex DNA to Present at the 2022 Jefferies Healthcare Conference - CODEX DNA
- Codex DNA Showcases Automated Synthetic Biology Solutions for Accelerating Discovery Workflows at the Antibody Engineering and Therapeutics Europe Conference - CODEX DNA
- Codex DNA Reports First Quarter 2022 Financial Results - CODEX DNA
- Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022 - CODEX DNA
- News Releases - CODEX DNA
- Codex DNA Unveils Automated Synthetic Biology Solutions for Antibody and Protein Engineering of Biotherapeutic Targets at 18th Annual PEGS Boston Conference and Expo - CODEX DNA
- News Releases - CODEX DNA
- Codex DNA Demonstrates End-to-End Workflow for Storing and Retrieving Data in Synthetic DNA - CODEX DNA
- View more press releases Close
关于 Telesis Bio 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Sarah Hlavinka 
